The Canadian Cardiovascular Society (CCS) is the national voice for cardiovascular physicians and scientists in Canada. The CCS contributes to improving the cardiovascular health and care of Canadians by leveraging its large national network of clinical experts to develop, maintain, promote and evaluate evidence-based clinical guidelines for prevention and management of cardiovascular risk and disease.
Since 2006, the CCS has developed and updated dyslipidemia guidelines to assist Canadian practitioners with clinical care. These guidelines are highly sought after as a practical guide; the 2012 Dyslipidemia Guideline is one of the most frequently downloaded articles from the Canadian Journal of Cardiology (CJC). In response to new evidence, the CCS Dyslipidemia Guideline writing panel is currently reviewing evidence and updating the recommendations. The 2016 Guideline will be ready for publication in the CJC in the spring of 2016.
As important as it is to develop and update clinical guidelines, it is equally important to support adoption and integration of the recommendations into patient care through knowledge translation. As such, the CCS is developing the Dyslipidemia Guideline Knowledge Translation (KT) Program that involves development and delivery of live, facilitated workshops, webinars, and educational tools and materials. The goal of the program is to promote the use of the latest dyslipidemia recommendations across the heath care spectrum and integrate them into patient care.